Home
| Databases
| WorldLII
| Search
| Feedback
Generic Top Level Domain Name (gTLD) Decisions |
G.D. Searle & Co. v. Interlocution,
Inc.
Claim Number: FA0209000124518
PARTIES
Complainant
is G.D. Searle & Co., Skokie,
IL, USA (“Complainant”) represented by Paul
D. McGrady, of Ladas & Parry. Respondent is Interlocution, Inc., Safat, KUWAIT (“Respondent”).
REGISTRAR AND DISPUTED DOMAIN NAME
The
domain name at issue is <ordercelebrex.com>,
registered with NamesDirect.
PANEL
The
undersigned certifies that he has acted independently and impartially and to
the best of his knowledge has no known conflict in
serving as Panelist in this
proceeding.
John
J. Upchurch as Panelist.
PROCEDURAL HISTORY
Complainant
submitted a Complaint to the National Arbitration Forum (the “Forum”)
electronically on September 4, 2002; the Forum received
a hard copy of the
Complaint on September 4, 2002.
On
September 11, 2002, NamesDirect confirmed by e-mail to the Forum that the
domain name <ordercelebrex.com>
is registered with NamesDirect and that Respondent is the current registrant of
the name. NamesDirect has verified that
Respondent is bound by the NamesDirect registration agreement and has thereby
agreed to resolve domain-name
disputes brought by third parties in accordance
with ICANN’s Uniform Domain Name Dispute Resolution Policy (the “Policy”).
On
September 16, 2002, a Notification of Complaint and Commencement of
Administrative Proceeding (the “Commencement Notification”),
setting a deadline
of October 7, 2002 by which Respondent could file a Response to the Complaint,
was transmitted to Respondent via
e-mail, post and fax, to all entities and
persons listed on Respondent’s registration as technical, administrative and
billing contacts,
and to postmaster@ordercelebrex.com by e-mail.
Having
received no formal Response from Respondent, using the same contact details and
methods as were used for the Commencement Notification,
the Forum transmitted
to the parties a Notification of Respondent Default.
On
October 25, 2002, pursuant to Complainant’s request to have the dispute decided
by a single-member Panel, the Forum appointed John
J. Upchurch as Panelist.
Having
reviewed the communications records, the Administrative Panel (the “Panel”)
finds that the Forum has discharged its responsibility
under Paragraph 2(a) of
the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”) “to
employ reasonably available
means calculated to achieve actual notice to
Respondent.” Therefore, the Panel may
issue its decision based on the documents submitted and in accordance with the
ICANN Policy, ICANN Rules,
the Forum’s Supplemental Rules and any rules and
principles of law that the Panel deems applicable, without the benefit of any
Response
from Respondent.
RELIEF SOUGHT
Complainant
requests that the domain name be transferred from Respondent to Complainant.
PARTIES’ CONTENTIONS
A.
Complainant
The
<ordercelebrex.com>
domain name is confusingly similar to Complainant's CELEBREX mark.
Respondent
has no rights or legitimate interests in the disputed domain name.
Respondent
registered and used the disputed domain name in bad faith.
B.
Respondent
Respondent
did not file a formal Response, however it did submit a two paragraph email
admitting that it should have refrained from
registering the domain name. Respondent also noted that it was willing to
transfer the domain name to Complainant.
FINDINGS
Complainant has registered its CELEBREX
mark in 112 countries around the world, including the United States. Complainant’s mark is registered on the
Principal Register of the Untied States Patent and Trademark Office as
Registration Number
2,321,622.
Complainant’s mark represents “pharmaceutical products in the nature of
anti-inflammatory analgesics.”
Complainant has promoted its CELEBREX mark on a global scale. Due to its extensive marketing and
advertising promoting the CELEBREX mark, the mark has earned worldwide
notoriety. The New York Times
referred to Complainant’s CELEBREX product as a “blockbuster arthritis drug,”
and Forbes referred to CELEBREX as the “sales crown jewel in Pharmacia’s
(Complainant) new portfolio.”
Respondent registered the disputed domain
name on June 6, 2002. Respondent has
made no use of the disputed domain name.
Respondent does not have a license from Complainant to use the CELEBREX
mark. Respondent has admitted that it
“should have refrained from registering the disputed domain name.” Respondent also stated in its correspondence
that it is willing to transfer the domain name to Complainant, and that it
volunteered
to do so before the initiation of this proceeding by Complainant.
DISCUSSION
Paragraph 15(a) of the Rules instructs this Panel to
“decide a complaint on the basis of the statements and documents submitted in
accordance with the Policy, these Rules and any rules and principles of law
that it deems applicable.”
In view
of Respondent's failure to submit a Response, the Panel shall decide this
administrative proceeding on the basis of the Complainant's
undisputed
representations pursuant to paragraphs 5(e), 14(a) and 15(a) of the Rules and
draw such inferences it considers appropriate
pursuant to paragraph 14(b) of
the Rules.
Paragraph
4(a) of the Policy requires that the Complainant must prove each of the
following three elements to obtain an order that
a domain name should be
cancelled or transferred:
(1) the domain name registered by Respondent
is identical or confusingly similar to a trademark or service mark in which
Complainant has
rights; and
(2)
Respondent has no rights or legitimate interests in respect of the domain name;
and
(3)
the domain name has been registered and is being used in bad faith.
Identical and/or Confusingly Similar
Complainant has established that it has
rights in the CELEBREX mark through registration with the United States Patent
and Trademark
Office and extensive use.
Respondent’s <ordercelebrex.com> domain
name is confusingly similar to Complainant’s mark because it incorporates
Complainant’s entire CELEBREX mark and merely appends
the word “order” in front
of it in the domain name. The addition
of the word “order” does not create a distinct mark because it is merely
communicating that Internet users can purchase
CELEBREX brand drugs at
Respondent’s domain name. Therefore,
Complainant’s CELEBREX mark is still the dominant element of the domain name
which is likely to cause consumer confusion
as to the source, sponsorship and
affiliation of the <ordercelebrex.com> domain name. See Perot
Sys. Corp. v. Perot.net, FA 95312 (Nat. Arb. Forum Aug. 29, 2000) (finding
that, given the similarity of
Complainant’s marks with the domain name, consumers will presume the
domain name is affiliated with Complainant; Respondent is attracting
Internet
users to a website, for commercial gain, by creating a likelihood of confusion
with Complainant’s mark as to the source,
sponsorship, or endorsement of
Respondent’s website); see also Broadcom
Corp. v. Domain Depot, FA 96854 (Nat. Arb. Forum Apr. 23, 2001) (finding
the <broadcomonline.com> domain name is confusingly similar to
Complainant’s
BROADCOM mark).
The Panel finds that Policy ¶ 4(a)(i) has
been satisfied.
Rights or Legitimate Interests
Although Respondent did not formally
Respond in this matter, it has communicated to the Panel that it should not
have registered the
domain name. This
informal communication is an admission that Respondent acknowledges that it has
no rights or legitimate interests in the disputed
domain name. Furthermore, Respondent has stated that it
is willing to transfer the domain name to Complainant. Based on these facts, it is clear that
Respondent admits that it does not have any rights or legitimate interests in
the disputed
domain name and therefore, Policy ¶ 4(a)(ii) has been
satisfied. See Marcor Int’l v. Langevin, FA 96317 (Nat.
Arb. Forum Jan. 12, 2001) (Respondent’s willingness to transfer the domain name
at issue indicates that it has no
rights or legitimate interests in the domain
name in question); see also Colgate-Palmolive
Co. v. Domains For Sale, FA 96248 (Nat. Arb. Forum Jan. 18, 2001)
(Respondent’s willingness to transfer the domain name at issue to Complainant,
as reflected
in its Response, is evidence that it has no rights or legitimate
interests in the domain name)
Registration and Use in Bad Faith
The UDRP Policy recognizes that there are
more situations that can give rise to bad faith registration and use than the particular
factors listed under Policy ¶ 4(b). See
Educational Testing Serv. v. TOEFL,
D2000-0044 (WIPO Mar. 16, 2000) (finding that the Policy “[I]ndicates that its
listing of bad faith factors is without limitation”);
see also Cellular One Group v. Brien, D2000-0028
(WIPO Mar. 10, 2000) (finding that the criteria specified in 4(b) of the Policy
is not an exhaustive list of bad faith
evidence).
Respondent has admitted that it should
not have registered the disputed domain name, and therefore it has also
admitted that it had
no legitimate reason for registering the disputed domain
name. Furthermore, Respondent
volunteered to do so before the initiation of this proceeding. Respondent’s own admission and behavior are
evidence that Respondent recognizes that it acted in bad faith when registering
and using
the disputed domain name. Furthermore,
based on the fame of Complainant’s CELEBREX mark and Respondent’s admission, it
is clear that Respondent was on notice
of Complainant’s mark when it registered
the disputed domain name and understood that its use of <ordercelebrex.com>
would infringe on Complainant’s mark. See Marcor Int’l v. Langevin, FA 96317
(Nat. Arb. Forum Jan. 12, 2001) (Respondent’s registration and use of the
domain name at issue coupled with its expressed
willingness to transfer the
name amply satisfies the bad faith requirements set forth in ICANN Policy); see
also Vertical Solutions Mgmt., Inc.
v. webnet-marketing, inc., FA 95095 (Nat. Arb. Forum July 31, 2000)
(finding Respondent’s willingness to transfer and its failure to develop the
site are evidence
of its bad faith registration and use).
Based on the above facts and admissions the Panel finds that
Policy ¶ 4(a)(iii) has been satisfied.
DECISION
Having established all three elements required
under the ICANN Policy, the Panel concludes that the requested relief shall be
hereby
granted.
Accordingly, it is Ordered that the
domain name <ordercelebrex.com>
be transferred from Respondent to Complainant.
John J. Upchurch, Panelist
Dated: October 28, 2002
WorldLII:
Copyright Policy
|
Disclaimers
|
Privacy Policy
|
Feedback
URL: http://www.worldlii.org/int/other/GENDND/2002/1476.html